| Schedule of segment reporting information, by segment |
|
|
|
Three months ended
|
| |
|
March 31,
2021
|
|
March 31,
2020
|
|
Segment Net Sales:
|
|
|
|
|
|
|
|
|
|
Cannabinoid
|
|
$
|
677 |
|
|
$
|
242 |
|
|
Non-Cannabinoid
|
|
|
2,800 |
|
|
|
2,672 |
|
|
Total Net Sales
|
|
|
3,477 |
|
|
|
2,914 |
|
| |
|
|
|
|
|
|
|
|
|
Segment Profit (Loss):
|
|
|
|
|
|
|
|
|
|
Cannabinoid
|
|
|
(2,864 |
)
|
|
|
(5,401 |
)
|
|
Non-Cannabinoid
|
|
|
612 |
|
|
|
480 |
|
|
Total Segment Loss
|
|
$
|
(2,252) |
|
|
$
|
(4,921) |
|
| |
|
|
|
|
|
|
|
|
|
Reconciliation:
|
|
|
|
|
|
|
|
|
|
Total Segment Loss
|
|
|
(2,252 |
)
|
|
|
(4,921 |
)
|
|
Unallocated corporate expenses
|
|
|
(3,387 |
)
|
|
|
(1,804 |
)
|
|
Non-cash share based compensation
|
|
|
(1,550 |
)
|
|
|
(416 |
)
|
|
Depreciation and amortization
|
|
|
(579 |
)
|
|
|
(352 |
)
|
|
Goodwill impairment
|
|
|
|
|
|
|
(1,682 |
)
|
|
Loss from operations
|
|
$
|
(7,768) |
|
|
$
|
(9,174) |
|
| |
|
|
|
|
|
|
|
|
|
Loss on fair value of derivative instrument
|
|
|
|
|
|
|
13 |
|
|
Loss(gain) on remeasurement of warrant liability
|
|
|
4,851 |
|
|
|
—
|
|
|
Loss on investments
|
|
|
|
|
|
|
161 |
|
|
Foreign exchange loss
|
|
|
759 |
|
|
|
48 |
|
|
Interest expense
|
|
|
978 |
|
|
|
836 |
|
|
Miscellaneous, net
|
|
|
(602 |
)
|
|
|
(57 |
)
|
|
Loss from operations before income taxes
|
|
$
|
(13,754 |
)
|
|
$
|
(10,175 |
)
|
|
|
|
March 31, 2021
|
|
December 31, 2020
|
|
Long-lived assets
|
|
|
|
|
|
|
|
Cannabinoid
|
|
$
|
27,148 |
|
$
|
25,485 |
|
Non-Cannabinoid
|
|
|
162 |
|
|
176 |
|
Other(a)
|
|
|
26 |
|
|
19 |
| |
|
$
|
27,336 |
|
$
|
25,680 |
|
|
|
|
Year ended
|
| |
|
December 31, 2020
(Restated)(a)
|
|
December 31, 2019
|
|
Segment Net Sales:
|
|
|
|
|
|
|
|
|
|
Cannabinoid
|
|
$
|
2,511 |
|
|
$
|
133 |
|
|
Non-Cannabinoid
|
|
|
9,606 |
|
|
|
7,701 |
|
|
Total Net Sales
|
|
|
12,117 |
|
|
|
7,834 |
|
| |
|
|
|
|
|
|
|
|
|
Segment Profit (Loss):
|
|
|
|
|
|
|
|
|
|
Cannabinoid
|
|
|
(18,798 |
)
|
|
|
(25,250 |
)
|
|
Non-Cannabinoid
|
|
|
1,863 |
|
|
|
614 |
|
|
Total Loss
|
|
$
|
(16,935 |
)
|
|
$
|
(24,636 |
)
|
| |
|
|
|
|
|
|
|
|
|
Reconciliation:
|
|
|
|
|
|
|
|
|
|
Total Segment Loss
|
|
|
(16,935 |
)
|
|
|
(24,636 |
)
|
|
Unallocated corporate expenses
|
|
|
(6,405 |
)
|
|
|
(5,887 |
)
|
|
Non-cash share based compensation
|
|
|
(1,652 |
)
|
|
|
(1,522 |
)
|
|
Depreciation and amortization
|
|
|
(1,854 |
)
|
|
|
(1,480 |
)
|
|
Herbal Brands acquisition related charges
|
|
|
|
|
|
|
(3,015 |
)
|
|
Goodwill impairment
|
|
|
(1,682 |
)
|
|
|
|
|
|
Loss from operations
|
|
$
|
(28,528 |
)
|
|
$
|
(36,540 |
)
|
| |
|
|
|
|
|
|
|
|
|
Loss on debt extinguishment
|
|
|
2,360 |
|
|
|
3,374 |
|
|
Gain on remeasurement of warrant liability
|
|
|
(10,780 |
)
|
|
|
—
|
|
|
Loss on fair value of derivative instrument
|
|
|
657 |
|
|
|
421 |
|
|
Loss on investments
|
|
|
464 |
|
|
|
756 |
|
|
Foreign exchange loss
|
|
|
491 |
|
|
|
1,575 |
|
|
Interest expense
|
|
|
4,455 |
|
|
|
2,684 |
|
|
Miscellaneous, net
|
|
|
(284 |
)
|
|
|
534 |
|
|
Loss from operations before income taxes
|
|
$
|
(25,891 |
)
|
|
$
|
(45,884 |
)
|
|
|
|
December 31, 2020
|
|
December 31, 2019
|
|
Long-lived assets
|
|
|
|
|
|
|
|
Cannabinoid
|
|
$
|
25,485 |
|
$
|
24,209 |
|
Non-Cannabinoid
|
|
|
176 |
|
|
207 |
|
Other(a)
|
|
|
19 |
|
|
16 |
| |
|
$
|
25,680 |
|
$
|
24,432 |
|
| Schedule of disaggregation of revenue by channel |
|
|
|
Three months ended
|
| |
|
March 31,
2021
|
|
March 31,
2020
|
|
Mass retail
|
|
$
|
1,888 |
|
$
|
1,021 |
|
Specialty, health and other retail
|
|
|
225 |
|
|
312 |
|
Distributors
|
|
|
1,232 |
|
|
1,339 |
|
E-commerce
|
|
|
132 |
|
|
242 |
| |
|
$
|
3,477 |
|
$
|
2,914 |
|
|
|
|
Year ended
|
| |
|
December 31, 2020
|
|
December 31, 2019
|
|
Mass retail
|
|
$
|
6,879 |
|
$
|
3,318 |
|
Specialty, health and other retail
|
|
|
689 |
|
|
1,235 |
|
Distributors
|
|
|
4,036 |
|
|
2,397 |
|
E-commerce
|
|
|
513 |
|
|
885 |
| |
|
$
|
12,117 |
|
$
|
7,834 |
|